13 results
Causes of Dyspnea - Differential Diagnosis Algorithm
Cardiac:
 • Dysrhythmia
 • Ischemia
 • Cardiomyopathy
 • Valvular disease
Causes of Dyspnea ... Differential Diagnosis Algorithm ... Emphysema • Cancer ... • Interstitial lung ... • Anemia • Reduced
Dyspnea - Considerations with Malignancy
Directly Malignancy Related:
 - Lymphangitic spread to lung
 - Malignant pleural effusion
Dyspnea - Considerations ... metastases Treatment ... - Radiation induced ... #algorithm #differential ... diagnosis #oncology #cancer
Acute-on-Chronic Liver Failure (ACLF) Clinical Guidelines

ACLF = possibly reversible condition in those with CLD (± cirrhosis)
) Clinical Guidelines ... months without treatment ... Brain Failure Lung ... Hepatitis (AAH) Drug-Induced ... gastroenterology #management
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... Chronic Obstructive Lung ... #Management #Pulmonary ... LAMA #LABA #ICS #Guidelines
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... antagonists; LABA: long-acting ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #Algorithm #Guidelines
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... thrombosis; PE = pulmonary ... #Algorithm #Anticoagulation ... #Management #Hematology
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... pain, hemoptysis, dyspnea ... Abscess Management ... foreign body, cancer ... #Abscess #pulmonary
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
• Amiodarone half ... starting amiodarone treatment ... Dyspnea 3. ... macrophages Treatment ... #management #Toxicology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
cancer • Septic ... hemoptysis • Dyspnea ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
cancer • Septic ... hemoptysis • Dyspnea ... Tuberculosis Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB